Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Saginaw, MI - Saturday, April 17, 2021

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 04/17/2021 at 8:00 AM (EDT)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Central Michigan University

    Saturday, April 17, 2021 | 8:00 am - 5:00 pm ET

    Live Virtual Course

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council


    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. SilverCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to infobuprenorphine@samhsa.hhs.gov. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior, Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • ASAM Criteria Course: Friday, December 18, 2020

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 12/18/2020 at 11:30 AM (EST)

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, December 18, 2020
    8:30 am - 5:30 pm PT

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a distance learning delivery method and the live webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities.

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based
    withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accreditation Statement:

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASWB Accreditation Statement:

    Social Workers: ASAM has applied for consideration of CE credits through ASWB ACE.

    NAADAC: 

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming. 

    California Association for Drug/Alcohol Educators (CAADE)


    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Programs (CADTP)


    This educational program is approved by CADTP, Provider #205

    ASAM CME Committee

    Name Commercial Interest Compensation Role
    Catherine R. Friedman, MD, DFASAM None NA NA
    Noel Ilogu, MD, MRCP, FASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA
    Edwin A. Salsitz, MD, DFASAM None NA NA
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM None NA NA
    Adam J. Gordon, MD, MPH, FACP, DFASAM None NA NA
    Zwaantje Hamming, FNP-C, CARN-AP None NA NA

    Program Planning Committee

    Name Commercial Interest Compensation Role
    Corey Waller, MD, MS, DFASAM, FACEP, Chair None NA NA
    David Mee-Lee, MD, FASAM None NA NA
    David R. Gastfriend, MD, DFASAM
    None NA NA
    Lewis Breitner, PhD, LADC, LMFT
    None NA NA
    Amy Davis, DO, MS, FACP, FAAHPM
    None NA NA
    Jennifer Harrison, PhD, LMSW, CAADC
    None NA NA
    Melissa Holland, MA, MD, FACOG, CAADC
    None NA NA
    Christine Mulford, RN, MSN, FNP-BC
    None NA NA
    Surita Rao, MBBS, FASAM
    None NA NA
    Gerald D. Shulman, MA, MAC, FACATA
    None NA NA

    ASAM Criteria Education Committee Consultants

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria
    David R. Gastfriend, MD, DFASAM 1. ASAM
    2. Alkermes
    3. Intent Solutions
    4. DynamiCare Health BiorCorRx, FEi Systems, Horizon BCBS, IBM Watson
    1. Royalty
    2. Stockholder
    3. Stock
    4. Stock, salary
    5. Fee
    1. Chief Architect (Agent) CONTINUUM
    2. Stockholder
    3. Consultant
    4. Chief Medical Officer & Co-Founder
    5. Consultant

    Faculty

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria

    ASAM CME Committee Reviewers

    Name Commercial Interest Compensation Role
    Adam Gordon, MD, MPH, FACP, CMRO, DFASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete all the content modules in the course located under "Course Content (5)." Each module contains instructional materials, interactive exercises, and knowledge checks. After completing the five modules, take the end of the course assessment.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • ASAM Criteria Course: Friday, November 20, 2020

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 11/20/2020 at 8:30 AM (EST)

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, November 20, 2020
    8:30 am - 5:30 pm ET

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a distance learning delivery method and the live webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities.

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based
    withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accreditation Statement:

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASWB Accreditation Statement:

    Social Workers: ASAM has applied for consideration of CE credits through ASWB ACE.

    NAADAC: 

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming. 

    California Association for Drug/Alcohol Educators (CAADE)


    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Programs (CADTP)


    This educational program is approved by CADTP, Provider #205

    ASAM CME Committee

    Name Commercial Interest Compensation Role
    Catherine R. Friedman, MD, DFASAM None NA NA
    Noel Ilogu, MD, MRCP, FASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA
    Edwin A. Salsitz, MD, DFASAM None NA NA
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM None NA NA
    Adam J. Gordon, MD, MPH, FACP, DFASAM None NA NA
    Zwaantje Hamming, FNP-C, CARN-AP None NA NA

    Program Planning Committee

    Name Commercial Interest Compensation Role
    Corey Waller, MD, MS, DFASAM, FACEP, Chair None NA NA
    David Mee-Lee, MD, FASAM None NA NA
    David R. Gastfriend, MD, DFASAM
    None NA NA
    Lewis Breitner, PhD, LADC, LMFT
    None NA NA
    Amy Davis, DO, MS, FACP, FAAHPM
    None NA NA
    Jennifer Harrison, PhD, LMSW, CAADC
    None NA NA
    Melissa Holland, MA, MD, FACOG, CAADC
    None NA NA
    Christine Mulford, RN, MSN, FNP-BC
    None NA NA
    Surita Rao, MBBS, FASAM
    None NA NA
    Gerald D. Shulman, MA, MAC, FACATA
    None NA NA

    ASAM Criteria Education Committee Consultants

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria
    David R. Gastfriend, MD, DFASAM 1. ASAM
    2. Alkermes
    3. Intent Solutions
    4. DynamiCare Health BiorCorRx, FEi Systems, Horizon BCBS, IBM Watson
    1. Royalty
    2. Stockholder
    3. Stock
    4. Stock, salary
    5. Fee
    1. Chief Architect (Agent) CONTINUUM
    2. Stockholder
    3. Consultant
    4. Chief Medical Officer & Co-Founder
    5. Consultant

    Faculty

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria

    ASAM CME Committee Reviewers

    Name Commercial Interest Compensation Role
    Adam Gordon, MD, MPH, FACP, CMRO, DFASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete all the content modules in the course located under "Course Content (5)." Each module contains instructional materials, interactive exercises, and knowledge checks. After completing the five modules, take the end of the course assessment.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • The ASAM Alcohol Withdrawal Management Webinar Series – Complicated Withdrawal & Special Populations

    Product not yet rated Contains 3 Component(s), Includes Credits Includes a Live Web Event on 11/17/2020 at 12:00 PM (EST)

    The fifth and final of its series, this webinar will provide an overview of the The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management's recommendations around both complicated withdrawal and special populations.

    image


    The ASAM Alcohol Withdrawal Management Webinar Series – Complicated Withdrawal & Special Populations


    The webinar follows the ASAM Alcohol Withdrawal Management Fundamentals webinar, which intends to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome, as written in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.

    Aspects of management may need to be adjusted for patients with or at risk for complicated AWS, such as the development of alcohol withdrawal seizure or alcohol withdrawal delirium, alcohol-induced psychotic disorder, or resistant alcohol withdrawal. Special considerations should also be given to specific populations including patients with medical conditions, patients who take opioids, and patients who are pregnant. This webinar will provide an overview of the treatment recommendations around both complicated withdrawal and special populations.

    Session Information

    Date: Tuesday, November 17 2020

    Time: 12:00 pm ET / 11:00 am CT/ 9:00 am PT

    Speaker(s): Darius Rastegar, MD, FASAM

    Learning Objectives

    By completing this session, you will be able to:

    • 1. Summarize the guideline’s treatment recommendations around complicated withdrawal and discuss how they should be used in practice. 
    • 2. Identify the different types of complicated withdrawal and how management should be adjusted for each.
    • 3. Describe the different special populations and how management should be adjusted for each.

    Darius Rastegar, MD, FASAM

    Associate Professor of Medicine, Johns Hopkins University School of Medicine

    Dr. Rastegar is a general internist and addiction specialist at Johns Hopkins Bayview Medical Center.  He provides outpatient primary care with a focus on caring for patients with substance use disorders, inpatient consultantions and is the medical director for an inpatient unit for treatment of substance withdrawal. He is also the program director for the Johns Hopkins Addiction Medicine fellowship and the co-author of the ASAM Handbook of Addiction Medicine.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Ed Salsitz, MD, DFASAM - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures

    Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures

    Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures

    Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures

    Dazhe Cao, MD – No Relevant Financial Disclosures

    George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder

    Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Oklahoma City, OK - Tuesday, November 10, 2020

    Product not yet rated Contains 7 Component(s), Includes Credits Includes a Live Web Event on 11/10/2020 at 8:00 AM (EST)

    The ASAM Treatment of Opioid Use Disorder Course: Includes Waiver Qualifying Requirements covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: Oklahoma Perinatal Quality Improvement Collaborative (OPQIC)

    Date: Tuesday, November 10, 2020 | 8:00 am - 12:30 pm CT

    Live Virtual Course

    Online Portion Due: Monday, November 9, 2020

    This course is offered in partnership with the American College of Obstetricians and Gynecologists (ACOG). The curriculum for this course has been specifically designed for women's health providers.

    Overview

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live in person or via live webinar learning. The live in person or via live webinar portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live in person or via live webinar portion. You must complete both portions to receive credit for the course. 

    Getting Started

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password.  If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    1. Identify the importance of screening for substance use disorders
    2. Describe the mechanism of opioid withdrawal
    3. Discuss options to treat opioid withdrawal
    4. Explain the safety and efficacy of buprenorphine to treat opioid use disorder
    5. Explain the safety of medications in antepartum, postpartum, and breastfeeding period
    6. Describe how to start a patient (induction) on buprenorphine in an office-based setting
    7. Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

    Overall Objective

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council

    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. ButchartCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - $25
      • Regular Member - $25
      • Retired - $25
      • Early Career Physician - $25
      • Resident - $25
      • Student - $25
      • Associate - $25
      • ASAM Staff - Free!
      • International Member - $25
      • Emeritus Member - $25
      • Provisional Member - $25
      • Fellow Member - $25
      • Honorary Member - $25
      • CRT Member - $25
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Portland, OR - Friday, November 6, 2020

    Product not yet rated Contains 7 Component(s), Includes Credits Includes a Live Web Event on 11/06/2020 at 11:00 AM (EST)

    The ASAM Treatment of Opioid Use Disorder Course: Includes Waiver Qualifying Requirements covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: Oregon Perinatal Quality Collaborative & Comagine Health

    Date: Friday, November 6, 2020 | 8:00 am - 12:30 pm PT 

    Live Virtual Course

    Online Portion Due: Thursday, November 6, 2020

    This course is offered in partnership with the American College of Obstetricians and Gynecologists (ACOG). The curriculum for this course has been specifically designed for women's health providers.

    Overview

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live in person or via live webinar learning. The live in person or via live webinar portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live in person or via live webinar portion. You must complete both portions to receive credit for the course. 

    Getting Started

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password.  If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    1. Identify the importance of screening for substance use disorders
    2. Describe the mechanism of opioid withdrawal
    3. Discuss options to treat opioid withdrawal
    4. Explain the safety and efficacy of buprenorphine to treat opioid use disorder
    5. Explain the safety of medications in antepartum, postpartum, and breastfeeding period
    6. Describe how to start a patient (induction) on buprenorphine in an office-based setting
    7. Discuss successful non-pharmacological ways to treat Neonatal Abstinence Syndrome

    Overall Objective

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council

    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. ButchartCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    • Register
      • Non-Member - $25
      • Regular Member - $25
      • Retired - $25
      • Early Career Physician - $25
      • Resident - $25
      • Student - $25
      • Associate - $25
      • ASAM Staff - Free!
      • International Member - $25
      • Emeritus Member - $25
      • Provisional Member - $25
      • Fellow Member - $25
      • Honorary Member - $25
      • CRT Member - $25
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - MOC - Monday, October 26, 2020

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 10/26/2020 at 8:00 AM (EDT)

    The ASAM Treatment of Opioid Use Disorder Course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices.

    image

    Host: Michigan Opioid Collaborative

    Monday, October 26, 2020 | 8:00 am - 5:00 pm ET

    Live Webinar

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council


    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. SilverCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior, Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Ask the Experts: Am I Ready for the Level of Care Certification?

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 10/23/2020 at 11:00 AM (EDT)

    This paneled Q&A is designed for participants who are early in their Level of Care Certification journey. It is geared to answer specific questions regarding Levels 3.1, 3.5, 3.7 and to explore the definable elements and how these may be incorporated into program policy, procedure and structure.

    image

    Ask the Experts: Am I Ready for the Level of Care Certification?


    ASAM Level of Care Certification is the first and only program of its kind to independently assess and verify the ability of treatment programs to deliver services consistent with the Levels of Care described in The ASAM Criteria. This paneled Q&A is designed for participants who are early in their Level of Care Certification journey. It is geared to answer specific questions regarding Levels 3.1, 3.5, 3.7 and to explore the definable elements and how these may be incorporated into program policy, procedure and structure.

    More information about ASAM Level of Care Certification can be found here.

    Session Information

    Date: Friday, October 23, 2020

    Time: 11 am ET / 10 am CT/ 8 am PT

    Experts:

    • Bradford Bobrin, MD
    • Thomas (Tim) Slavin, PhD

    Learning Objectives

    By completing this webinar, you will be able to:

    1. Identify the standards and rating elements needed for the levels of care you are seeking. 
    2. Define how your organization addresses service characteristics as it relates to the level of care you are seeking. 
    3. Describe how the Level of Care requirements are reflected in your organizations  policy and procedures.

    Bradford Bobrin

    MD, FASAM, DABAM, DABPM

    Dr Bobrin is a graduate of Lafayette College and Hahnemann University School of Medicine.  He completed an internship in Pediatrics at Rainbow Babies and Childrens Hospital and a residency in Psychiatry at UMass Medical Center. He also completed a fellowship in Consult Psychiatry at Cambridge Hospital and a fellowship in Geriatric Psychiatry at Long Island Jewish Medical Center.

    Dr Bobrin is currently board certified in Adult Psychiatry, Geriatric Psychiatry, Consult Psychiatry, Neuropsychiatry, Addiction Medicine by both ABAM and ABPM and boarded in Pain Medicine.

    His current position is Medical Director of Addiction Services at Atlanticare Regional Medical center in New Jersey and Medical Director for the Community Care Behavioral Health Clinic for Atlanticare as well.

     

    Thomas (Tim) Slaven

    PhD

    Dr. Tim Slaven holds a Ph.D. and a Certificate of Advanced Study (CAS) in Urban Studies (Health Care Administration and Counseling) from Old Dominion University, and a Master degree in Counseling Psychology from Ball State University. He is a Licensed Professional Counselor (LPC) and Board-Approved Supervisor in Virginia; he is certified by the National Board of Certified Counselors (NCC).

    Dr. Slaven is the former National Director of the Behavioral Health Division at CARF, the Rehabilitation Accreditation Commission, Project Director of the National Opioid Treatment Accreditation Project, and he is the former Executive Director of Hanover Community Services Board.

    Dr. Slaven is a Diplomate of the American Mental Health Counselors Association, Clinical Mental Health Specialist and National Board of Certified Clinical Counselors. Previously Dr. Slaven has taught at Virginia Commonwealth University (VCU), Duke University, and Radford University. 

    • Register
      • Non-Member - $99
      • Regular Member - $75
      • Retired - $75
      • Early Career Physician - $75
      • Resident - $75
      • Student - $75
      • Associate - $75
      • ASAM Staff - Free!
      • International Member - $75
      • Emeritus Member - $75
      • Provisional Member - $75
      • Fellow Member - $75
      • Honorary Member - $75
      • CRT Member - $75
    • More Information
  • Rebroadcasting: Motivational Interviewing: Strategic Patient Engagement and Reflective Listening

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 10/22/2020 at 12:00 PM (EDT)

    This will be a rebroadcasting of the recorded webinar with LIVE audience question and answer. The workshop engages participants using principles of motivational interviewing in the teaching methodology to build participants’ motivation to use and familiarity with the technique of motivational interviewing in clinical practice.

    This will be a rebroadcasting of the recorded webinar with LIVE audience question and answer.

    The workshop engages participants using principles of motivational interviewing in the teaching methodology to build participants’ motivation to use and familiarity with the technique of motivational interviewing in clinical practice. Real play and other practical exercises will give participants the experience to implement the motivational interviewing approach immediately into their practice. Participants will practice informal coding of an interaction followed by review and discussion to learn how to identify factors that facilitate the motivational interview, and how to gauge success by learning to listen for change talk.

    Rebroadcasting Session:

    Date: Thursday October 22, 2020

    Time: 12:00 pm ET / 11:00 am CT/ 9:00 am PT

    Expert for Q&A: Brian Hurley, MD, MBA, DFASAM

    Learning Objectives

    – Participants will be able to explain and understand how to use the spirit of MI
    – Participants will be able to identify and utilize MI micro-skills to facilitate a conversation with patients
    – Participants will be able to identify change talk, “coding” an MI encounter, and perform these in clinical practice

    Dr. Brian Hurley, MD, MBA, DFASAM

    Director of Addiction Medicine, Los Angeles County Department of Health Services

    Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. As Director-at-Large, Brian currently serves as a board member of ASAM and gives presentations around the world regarding addiction medicine. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Treatment Starts Here program through the Center for Clinical Innovation, focused on increasing the delivery of medications for addiction treatment in California’s community health centers. He is a senior researcher at the Friends Research Institute and is a primary investigator on a Tobacco Related Disease Prevention Program-funded project integrating smoking cessation services into community mental health centers and patient-centered medical homes and is the grant lead for three Medications for Addiction Treatment Access Points projects funded by the Sierra Health Foundation supporting access to medications for addiction treatment across Los Angeles County. He is also a co-investigator for several Rand Corporation projects evaluating the integration of substance use disorder treatment within community mental health and Federally Qualified Health Center settings. He also serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry Examination Writing Committee. Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA) and is an alumnus of the Massachusetts General Hospital and McLean Hospital Psychiatry Residency Training Program and the New York University Addiction Psychiatry Fellowship. Additionally, he has served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.

    • Register
      • Non-Member - $39
      • Regular Member - $29
      • Retired - $29
      • Early Career Physician - $29
      • Resident - $19
      • Student - $19
      • Associate - $19
      • ASAM Staff - Free!
      • International Member - $29
      • Emeritus Member - $29
      • Provisional Member - $29
      • Fellow Member - $29
      • Honorary Member - $29
      • CRT Member - $29
    • More Information
  • Rebroadcasting: So You want to be an Addiction Doc?: Career Pathways in Addiction

    Product not yet rated Contains 4 Component(s), Includes Credits Includes a Live Web Event on 10/21/2020 at 2:00 PM (EDT)

    This will be a rebroadcasting of the recorded webinar with LIVE audience question and answer. In the setting of the opioid epidemic, there has been a call for enhanced and expanded medical education in substance use disorders. As the number of addiction medicine physicians completing training grows, so too do the multiple career pathways within the field. From inpatient and outpatient settings to private, public, and academic domains, a newly trained fellow or medical trainee can explore a diverse number of career options. Many fellows are engaged primarily in academic environments and are not exposed to the variety of career trajectories in the field. This session seeks to assist those who are early in their career who are either interested in or committed to addiction medicine.

    This will be a rebroadcasting of the recorded webinar with LIVE audience question and answer.

    In the setting of the opioid epidemic, there has been a call for enhanced and expanded medical education in substance use disorders.  As the number of addiction medicine physicians completing training grows, so too do the multiple career pathways within the field.  From inpatient and outpatient settings to private, public, and academic domains, a newly trained fellow or medical trainee can explore a diverse number of career options. Many fellows are engaged primarily in academic environments and are not exposed to the variety of career trajectories in the field. This session seeks to assist those who are early in their career who are either interested in or committed to addiction medicine.

    Rebroadcasting Session:

    Date: Wednesday October 21, 2020

    Time: 2:00 pm ET / 1:00 pm CT/ 11:00 am PT

    Expert for Q&A: Dr. Kinna Thakarar, DO, MPH

    Learning Objectives

    – Exemplify different career paths after completion of addiction medicine training
    - Examine the variety of disciplines (general internal medicine, adolescent medicine, infectious disease) that can be integrated with addiction training to serve affected patients
    – Inform future educational endeavors on career development in addiction medicine

    Dr. Kinna Thakarar, DO, MPH

    Assistant Professor of Medicine, Maine Medical Center

    Dr. Kinna Thakarar is an Assistant Professor of Medicine at Maine Medical Center/Tufts University School of Medicine in Portland, Maine. She is board-certified in internal medicine, infectious diseases, and addiction medicine and has a special interest in health services research related to the ID/ substance use disorder syndemic. Dr. Thakarar is currently an affiliated investigator at the Center for Outcomes Research and Evaluation in Maine and is the PI of a pilot study supported by grant U54 GM115516 from the National Institutes of Health for the Northern New England Clinical and Translational Research network, titled "Rural Harm Reduction Access and Regional Trends Among People Hospitalized with Injection Drug Use-Associated Infections." She completed ID fellowship and additional addiction medicine training at Boston Medical Center.

    Dr. Shonali Saha, MD, FASAM

    CEO and Practice Owner, Whole and Healthy You Addiction Medicine Services

    Shonali Saha, MD is a board-certified internal and addiction medicine specialist. She completed fellowships in both addiction and adolescent medicine at Johns Hopkins School of Medicine. She completed her residency program at Cambridge Health Alliance of Harvard Medical School.

    Dr. Saha began working in the field of substance abuse in 1996 with women mandated to residential drug treatment. She currently treats substance use disorders in adolescents, adults, and families in her own private practice. She also educates medical students, residents, and faculty on addiction medicine as an adjunct assistant professor at Emory School of Medicine and as a preceptor for physician assistant students at Mercer University.

    As an active member of The Georgia Society of Addiction Medicine and a former member of The American Society of Addiction Medicine legislative committee, she is an advocate for the improvement and expansion of addiction medicine services locally and nationally.

    Dr. Saha is not only a doctor, but also a certified yoga instructor. She teaches her patients breathing and other stress reduction techniques to provide evidence based treatment.

    Dr. J. Deanna Wilson, MD, MPH

    Assistant Professor of Medicine and Pediatrics, University of Pittsburgh

    Dr. Deanna Wilson is an Assistant Professor of Medicine and Pediatrics at the University of Pittsburgh School of Medicine. She received her MD from Yale University School of Medicine and trained in internal medicine and pediatrics at the Johns Hopkins University School of Medicine. She completed additional subspecialty training in both adolescent and addiction medicine also at Johns Hopkins. She currently sees patients at UPMC’s Center for Opioid Recovery, a Pennsylvania Center of Excellence. She provides inpatient addiction medicine consultation to patients hospitalized at UPMC Presbyterian Hospital and is Medical Director for an outpatient substance use treatment clinic providing care for patients with HIV and substance use disorder. She has expertise in integrating harm reduction, substance use treatment, and primary care into clinical practice. Her current research interests are in using claims data to examine trajectories of opioid use in adolescents following first opioid exposure and also in the design and evaluation of interventions to engage and retain hospitalized young adults who inject drugs into substance use treatment.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information